Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysis

Por RENY, J.-L., COMBESCURE, C., DAALI, Y., FONTANA, P.
Publicado em 2012

Applications of CYP450 Testing in the Clinical Setting

Por Samer, C. F., Lorenzini, K. Ing, Rollason, V., Daali, Y., Desmeules, J. A.
Publicado em 2013

Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model

Por Marsousi, N, Daali, Y, Rudaz, S, Almond, L, Humphries, H, Desmeules, J, Samer, C F
Publicado no CPT Pharmacometrics Syst Pharmacol (2014)

The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro

Por Ancrenaz, V, Desmeules, J, James, R, Fontana, P, Reny, J-L, Dayer, P, Daali, Y
Publicado em 2012

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone

Por Samer, CF, Daali, Y, Wagner, M, Hopfgartner, G, Eap, CB, Rebsamen, MC, Rossier, MF, Hochstrasser, D, Dayer, P, Desmeules, JA
Publicado em 2010

Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety

Por Samer, CF, Daali, Y, Wagner, M, Hopfgartner, G, Eap, CB, Rebsamen, MC, Rossier, MF, Hochstrasser, D, Dayer, P, Desmeules, JA
Publicado em 2010

Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots

Por Bosilkovska, M, Samer, C F, Déglon, J, Rebsamen, M, Staub, C, Dayer, P, Walder, B, Desmeules, J A, Daali, Y
Publicado em 2014